Attracting Talent to Strengthen the Industrial Chain! Zhejiang JibaiChuan Pharmaceutical and National-Level Young Talent Xie Jing Sign an Industry-Integration Project Agreement.
Release date:
2026-05-15
On May 15, 2026, at the grand “Pan’an County Symposium on Innovative Development of the Traditional Chinese Medicine and Greater Health Industry and the Second Meeting of the Precision Medicine Industry Alliance” held in Pan’an, Zhejiang, JibaiChuan Pharmaceutical officially signed a cooperation agreement with Mr. Xie Jing, a national-level young talent and a Ph.D. in epidemiology from Harvard University. The two parties will jointly advance projects aimed at industrial integration.
The signing ceremony was held during the afternoon’s “Traditional Chinese Medicine and Greater Health Symposium.”
This collaboration, a flagship example of industrial integration and innovation within Pan’an County, marks a pivotal step for JibaiChuan Pharmaceutical in pioneering an integrated development model that combines traditional Chinese medicine, modern biotechnology, and artificial intelligence.
The details of the projects signed this time are as follows:
Leveraging the AI and real-world data technologies of Dr. Xie Jing’s team, we have identified the key bioactive compounds in wild‑grown Ganoderma lucidum and, using synthetic biology, achieved efficient biosynthesis and large‑scale production, thereby establishing a complete industrial closed loop—from raw materials to finished products.
The implementation of this project carries significant strategic importance. As Pan’an County’s first industry‑integration initiative combining traditional Chinese medicine with precision medicine, it has successfully attracted top‑tier talent and cutting‑edge technologies, setting an innovative benchmark for the transformation and upgrading of the county’s traditional industries.
- Xie Jing
- National-level young talent
- Ph.D. in Epidemiology, Harvard University
- Main research areas: epidemiology, biostatistics, and real-world evidence.
Xie Jing holds a Bachelor’s degree in Preventive Medicine from Zhejiang University, a Master’s degree in Public Health from Emory University, and a Ph.D. in Epidemiology from Harvard University, with a solid academic foundation and a comprehensive research training program.
He previously worked at Brigham and Women’s Hospital, affiliated with Harvard Medical School, where he focused on real-world observational studies of drug efficacy and adverse effects, and has presented his research findings at numerous international conferences.
In the pharmaceutical industry, Dr. Xie Jing has held director‑level and senior management positions at internationally renowned companies including Pfizer, Kite Pharma (Gilead Sciences), and AstraZeneca, where he was responsible for global real‑world evidence strategy development, the acquisition and execution of innovative projects, and the recruitment of top talent.
He has amassed extensive experience in the design, analysis, and application of real-world evidence, providing critical support for drug development, market access, and clinical practice.
This strategic collaboration between JibaiChuan Pharmaceutical and Dr. Xie Jing represents a key initiative for the company to deepen its innovation-driven strategy and actively integrate into the broader development of the Pan’an Precision Medicine Industrial Park.
Looking ahead, JibaiChuan will remain committed to pioneering the cutting edge of the traditional Chinese medicine and greater health industry, partnering with top-tier talent to jointly usher in a new chapter of high-quality development for Pan’an’s TCM sector.
Related Recommendations
Making traditional Chinese medicine more effective, making life healthier.
Service Hotline
Company Address
No. 29, Yaoxiang East Road, Xinwo Subdistrict, Pan’an County, Zhejiang Province
Contact email
